- Patent Title: Glycolysis-activating agents for treatment or prevention of disease
-
Application No.: US16647440Application Date: 2018-09-13
-
Publication No.: US11690841B2Publication Date: 2023-07-04
- Inventor: Federica Maria Marelli-Berg
- Applicant: Queen Mary University of London
- Applicant Address: GB London
- Assignee: Queen Mary University of London
- Current Assignee: Queen Mary University of London
- Current Assignee Address: GB London
- Agency: Holland & Hart LLP
- Priority: GB 14777 2017.09.14
- International Application: PCT/GB2018/052603 2018.09.13
- International Announcement: WO2019/053435A 2019.03.21
- Date entered country: 2020-03-13
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/44 ; A61K31/366 ; A61P37/06 ; A61K9/00 ; A61K45/06
Abstract:
The present invention relates to glycolysis-activating agents. The present invention also relates to the treatment or prevention of diseases or medical conditions, in particular immune-related diseases or medical conditions. In particular, the present invention also relates to agents for use in the treatment or prevention of a disease or medical condition, which treatment or prevention is mediated via the trafficking of endogenous regulatory T cells (Tregs).
Public/Granted literature
- US20200268750A1 AGENT Public/Granted day:2020-08-27
Information query
IPC分类:
